Search Results 61-70 of 19709 for lupus
Clinical Trials · Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V · More about research at Mayo Clinic.
About this study. This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus ...
... Lupus Erythematosus International Collaborating Clinics group//European Lupus Society rare systemic lupus erythematosus taskforce member panel. ERN ReCONNET ...
The purpose of this study is to evaluate the safety and tolerability of CABA-201 in subjects with active Systemic Lupus Erythematosus. Participation eligibility.
However, this medicine is not used to treat severe or complicated malaria. Hydroxychloroquine is used to treat discoid lupus erythematosus (DLE) or systemic ...
Mayo Clinic experts are actively researching lupus and testing new treatments for lupus nephritis through the Mayo Nephrology Collaborative Group. As a Mayo ...
Science Saturday: Lupus rates increasing, communities of color especially vulnerable featured image. Science Saturday. Science Saturday: Lupus rates ...
The purpose of this study is to investigate the role of nailfold capillaroscopy in the assessment of patients with Systemic Lupus Erythematosus (SLE).
Lupus often causes a facial rash that resembles the wings of a butterfly. Mixed connective tissue disease. Early symptoms of this disease often involve the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.